This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

AVEO Pharmaceuticals Inc (AVEO)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 50.83M 76.13M 43.51M 45.79M
Receivables 6.82M 20.65M 7.21M 391.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 128.92M 190.68M 234.40M 145.45M
Property, Plant & Equipment, Gross 29.14M 25.40M 16.53M 14.29M
Accumulated Depreciation & Depletion 15.00M 12.54M 11.06M 9.75M
Property, Plant & Equipment, Net 14.14M 12.87M 5.47M 4.53M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 3.29M 3.92M 55.18M 1.06M
Total Non-Current Assets 17.43M 16.79M 60.66M 5.60M
Liabilities & Shareholder Equity
Total Assets 146.35M 207.47M 295.05M 151.05M
Accounts Payable 4.24M 10.63M 8.90M 9.25M
Short Term Debt 10.38M 6.81M 8.55M 5.77M
Other Current Liabilities 2.23M 2.02M 1.25M 266.00K
Total Current Liabilities 31.41M 39.13M 34.61M 42.09M
Long Term Debt 8.82M 19.23M 15.62M 17.64M
Deferred Income Taxes 19.08M 10.54M 0.00 553.00K
Other Non-Current Liabilities 17.10M 19.63M 21.28M 19.00M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 45.00M 49.40M 36.90M 37.18M
Total Liabilities 76.41M 88.53M 71.51M 79.28M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 69.94M 118.94M 223.54M 71.77M
Common Par 52.00K 44.00K 43.00K 36.00K
Additional Paid In Capital 497.18M 439.17M 429.53M 308.27M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -427.29M -320.26M -205.87M -236.51M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -2.00K -19.00K -167.00K -20.00K
Total Capitalization 78.76M 138.17M 239.16M 89.41M
Total Equity 69.94M 118.94M 223.54M 71.77M
Total Liabilities & Stock Equity 146.35M 207.47M 295.05M 151.05M
Total Common Shares Outstanding 51.81M 43.78M 43.25M 35.60M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 50.93M 43.37M 39.72M 25.58M
Diluted Weighted Shares Outstanding 50.93M 43.37M 41.47M 25.58M
Number of Employees 71 219 220 147
Number of Part-Time Employees 0 0 0 0
AVEO News

AVEO AVEO Pharmaceuticals Inc

Analysts Ratings for AVEO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET AVEO ANALYST REPORT

Brokerage Partners

AVEO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs